Checkpoint inhibitor induced myositis – The value of MRI STIR

Mai Erritzøe-Jervild; David Scheie; Christian Stenør

doi:10.1016/j.ensci.2022.100442

Checkpoint inhibitor induced myositis – The value of MRI STIR

Mai Erritzøe-Jervild^*, David Scheie, Christian Stenør

^*Corresponding author af dette arbejde

2 Citationer (Scopus)

Abstract

•Treatment with immune checkpoint inhibitors can cause serious adverse events.•Myositis combined with myocarditis ad adverse event have a mortality for 50%.•Early diagnosis is important for better outcome.•Employing MRI STIR can rapidly diagnose, guide biopsy, and classify cases of immune-related myositis.

Originalsprog	Engelsk
Artikelnummer	100442
Tidsskrift	eNeurologicalSci
Vol/bind	30
DOI	https://doi.org/10.1016/j.ensci.2022.100442
Status	Udgivet - mar. 2023

Adgang til dokumentet

10.1016/j.ensci.2022.100442Licens: CC BY-NC-ND

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{d0aad5b329174099a2c8b1c06407333f,

title = "Checkpoint inhibitor induced myositis – The value of MRI STIR",

abstract = "•Treatment with immune checkpoint inhibitors can cause serious adverse events.•Myositis combined with myocarditis ad adverse event have a mortality for 50%.•Early diagnosis is important for better outcome.•Employing MRI STIR can rapidly diagnose, guide biopsy, and classify cases of immune-related myositis.",

author = "Mai Erritz{\o}e-Jervild and David Scheie and Christian Sten{\o}r",

year = "2023",

month = mar,

doi = "10.1016/j.ensci.2022.100442",

language = "English",

volume = "30",

journal = "eNeurologicalSci",

issn = "2405-6502",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Checkpoint inhibitor induced myositis – The value of MRI STIR

AU - Erritzøe-Jervild, Mai

AU - Scheie, David

AU - Stenør, Christian

PY - 2023/3

Y1 - 2023/3

N2 - •Treatment with immune checkpoint inhibitors can cause serious adverse events.•Myositis combined with myocarditis ad adverse event have a mortality for 50%.•Early diagnosis is important for better outcome.•Employing MRI STIR can rapidly diagnose, guide biopsy, and classify cases of immune-related myositis.

AB - •Treatment with immune checkpoint inhibitors can cause serious adverse events.•Myositis combined with myocarditis ad adverse event have a mortality for 50%.•Early diagnosis is important for better outcome.•Employing MRI STIR can rapidly diagnose, guide biopsy, and classify cases of immune-related myositis.

UR - http://www.scopus.com/inward/record.url?scp=85145702550&partnerID=8YFLogxK

U2 - 10.1016/j.ensci.2022.100442

DO - 10.1016/j.ensci.2022.100442

M3 - Journal article

C2 - 36683900

AN - SCOPUS:85145702550

SN - 2405-6502

VL - 30

JO - eNeurologicalSci

JF - eNeurologicalSci

M1 - 100442

ER -

Checkpoint inhibitor induced myositis – The value of MRI STIR

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater